Risk and prognosis of second primary malignancies in patients with follicular lymphoma in the era of rituximab: A population study based on the SEER database

• Ying Tian,

  Roles Data curation, Software, Writing – original draft

  Current Address: No. 37 Guoxue Xiang, District Wuhou, Chengdu, Sichuan, China

  Affiliation Department of Hematology, Institute of Hematology, West China Hospital, Sichuan University, Chengdu, China

  https://orcid.org/0000-0001-9521-368X

  ⨯
• Wanxi Yang,

  Roles Data curation, Writing – original draft

  Current Address: No. 37 Guoxue Xiang, District Wuhou, Chengdu, Sichuan, China

  Affiliation Department of Hematology, Institute of Hematology, West China Hospital, Sichuan University, Chengdu, China

  ⨯
• Juan Xu,

  Roles Resources, Supervision, Writing – original draft

  Current Address: No. 37 Guoxue Xiang, District Wuhou, Chengdu, Sichuan, China

  Affiliation Department of Hematology, Institute of Hematology, West China Hospital, Sichuan University, Chengdu, China

  ⨯
• Yuanxiao Li,

  Roles Methodology, Writing – original draft

  Current Address: 82 Cuiyingmen Street, Chengguan District, Lanzhou, Gansu Province, China

  Affiliation Department of Pediatric Gastroenterology, Lanzhou University Second Hospital, Lanzhou, China

  ⨯
• Wenjiao Tang,

  Roles Methodology, Resources

  Current Address: No. 37 Guoxue Xiang, District Wuhou, Chengdu, Sichuan, China

  Affiliation Department of Hematology, Institute of Hematology, West China Hospital, Sichuan University, Chengdu, China

  ⨯
• Caigang Xu

  Roles Conceptualization, Resources, Supervision, Writing – review & editing

  * E-mail: xucaigang@wchscu.cn

  Current Address: No. 37 Guoxue Xiang, District Wuhou, Chengdu, Sichuan, China

  Affiliation Department of Hematology, Institute of Hematology, West China Hospital, Sichuan University, Chengdu, China

  https://orcid.org/0000-0003-0549-4065

  ⨯